Epileptic Seizures

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

FDA approval · 2024-12-17
FDA Approved: VIGABATRIN — Supplemental Application (Amneal Pharmaceuticals NY LLC)
The FDA approves a supplemental application for Vigabatrin from Amneal Pharmaceuticals NY LLC.